nalmefene has been researched along with Disruptive, Impulse Control, and Conduct Disorders in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Astrup, A; Christensen, R; Johansen, KGV; Lund, H; Pagsberg, AK; Tarp, S | 1 |
| Fontenelle, LF; Piquet-Pessôa, M | 1 |
| Allen, AR; Balleine, B; Carter, A; Clark, L; Dowling, NA; Gainsbury, SM; Goudriaan, AE; Grant, J; Hall, W; Hayes, A; Hodgins, D; Lattimore, R; Livingstone, C; Lorenzetti, V; Lubman, D; Murawski, C; Parkes, L; Petry, N; Room, R; Singh, B; Thomas, A; Townshend, P; van Holst, R; Youssef, G; Yücel, M | 1 |
| Blanco, C; Grant, JE; Hollander, E; Kim, SW; Potenza, MN | 1 |
| Cunningham-Williams, R; Grant, JE; Hollander, E; Kallio, A; Nurminen, T; Potenza, MN; Smits, G | 1 |
| Kim, SW | 1 |
3 review(s) available for nalmefene and Disruptive, Impulse Control, and Conduct Disorders
| Article | Year |
|---|---|
Harms associated with taking nalmefene for substance use and impulse control disorders: A systematic review and meta-analysis of randomised controlled trials.
Topics: Disruptive, Impulse Control, and Conduct Disorders; Humans; Naltrexone; Substance Withdrawal Syndrome; Substance-Related Disorders | 2017 |
Opioid antagonists in broadly defined behavioral addictions: a narrative review.
Topics: Alcoholism; Bulimia; Compulsive Behavior; Disruptive, Impulse Control, and Conduct Disorders; Gambling; Humans; Naltrexone; Narcotic Antagonists; Obsessive-Compulsive Disorder; Randomized Controlled Trials as Topic; Trichotillomania | 2016 |
Neuroscience in gambling policy and treatment: an interdisciplinary perspective.
Topics: Administrative Personnel; Appetite Depressants; Decision Making; Diagnostic and Statistical Manual of Mental Disorders; Disruptive, Impulse Control, and Conduct Disorders; Gambling; Harm Reduction; Humans; Naloxone; Naltrexone; Narcotic Antagonists; Neurosciences; Public Health | 2017 |
2 trial(s) available for nalmefene and Disruptive, Impulse Control, and Conduct Disorders
| Article | Year |
|---|---|
The Gambling Symptom Assessment Scale (G-SAS): a reliability and validity study.
Topics: Disruptive, Impulse Control, and Conduct Disorders; Follow-Up Studies; Gambling; Humans; Naltrexone; Narcotic Antagonists; Obsessive-Compulsive Disorder; Personality Inventory; Psychometrics; Reproducibility of Results | 2009 |
Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling.
Topics: Adult; Age of Onset; Ambulatory Care; Behavior, Addictive; Disruptive, Impulse Control, and Conduct Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drugs, Investigational; Female; Gambling; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Obsessive-Compulsive Disorder; Placebos; Psychiatric Status Rating Scales; Severity of Illness Index; Treatment Outcome | 2006 |
1 other study(ies) available for nalmefene and Disruptive, Impulse Control, and Conduct Disorders
| Article | Year |
|---|---|
Opioid antagonists in the treatment of impulse-control disorders.
Topics: Adult; Compulsive Behavior; Disruptive, Impulse Control, and Conduct Disorders; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gambling; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists | 1998 |